← Back to Search

Mamma Mia App for Perinatal Wellness

Q: Are there any available slots to partake in this clinical experiment?

<p>The clinical trial website indicates that this study is open for patient enrollment. The initial post date was October 15th, 2020 and the most recent update to information occurred on October 31st, 2022.</p>

Q: How many individuals is the research team enrolling in this experiment?

<p>Affirmative. According to clinicaltrials.gov, this trial is still searching for individuals to join it; the initial post was on October 15th 2020 and the information has been updated as recently asOctober 31st 2022. The study seeks 2000 participants from a single medical facility.</p>

N/A

Waitlist Available

Led By Patricia A Kinser, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

have the ability to access an internet/mobile-based program (via computer, tablet, or smartphone), and have a working phone number and a working email address.

pregnant woman <25 weeks gestation;

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6 months postpartum, about 11 months

Awards & highlights

Study Summary

This trial is testing an app to see if it can help improve wellbeing for pregnant women and new mothers.

Who is the study for?

This trial is for pregnant women under 25 weeks gestation, aged 18 or older, who speak English and can access internet/mobile-based programs. They must have a working phone number and email address.Check my eligibility

What is being tested?

'Mamma Mia' is an app designed to improve well-being during pregnancy and after birth. The study compares the standard 'Mamma Mia' program with 'Mamma Mia Plus,' which includes extra support from staff.See study design

What are the potential side effects?

Since 'Mamma Mia' and 'Mamma Mia Plus' are non-medical interventions involving an app and guided support, they're not expected to cause physical side effects but may impact emotional or mental health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can use the internet on a device and have a working phone and email.

Select...

I am pregnant and less than 25 weeks along.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6 months postpartum, about 11 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6 months postpartum, about 11 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months postpartum, about 11 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mental Depression

Secondary outcome measures

Anxiety

Change in stress

Change in subjective well-being

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Mamma Mia groupExperimental Treatment1 Intervention

Usual prenatal/postpartum care plus use of the "Mamma Mia" program

Group II: Mamma Mia Plus groupExperimental Treatment2 Interventions

Usual prenatal/postpartum care plus use of the "Mamma Mia" program plus occasional contacts from study staff

Group III: Usual care groupActive Control1 Intervention

Usual prenatal and postpartum care involves regular visits with one's health care provider while pregnant and after the baby is born.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

697 Previous Clinical Trials

22,883,044 Total Patients Enrolled

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,963 Previous Clinical Trials

2,672,789 Total Patients Enrolled

6 Trials studying Postpartum Depression

4,286 Patients Enrolled for Postpartum Depression

Patricia A Kinser, PhDPrincipal InvestigatorVirginia Commonwealth University

2 Previous Clinical Trials

68 Total Patients Enrolled

Media Library

Mamma Mia Clinical Trial Eligibility Overview. Trial Name: NCT04300894 — N/A

Postpartum Depression Research Study Groups: Usual care group, Mamma Mia group, Mamma Mia Plus group

Postpartum Depression Clinical Trial 2023: Mamma Mia Highlights & Side Effects. Trial Name: NCT04300894 — N/A

Mamma Mia 2023 Treatment Timeline for Medical Study. Trial Name: NCT04300894 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots to partake in this clinical experiment?

"The clinical trial website indicates that this study is open for patient enrollment. The initial post date was October 15th, 2020 and the most recent update to information occurred on October 31st, 2022."

Answered by AI

How many individuals is the research team enrolling in this experiment?

"Affirmative. According to clinicaltrials.gov, this trial is still searching for individuals to join it; the initial post was on October 15th 2020 and the information has been updated as recently asOctober 31st 2022. The study seeks 2000 participants from a single medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

"Mamma Mia" for Perinatal Health and Wellness

2020. ""Mamma Mia" for Perinatal Health and Wellness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04300894.